Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Intelgenx Technologies Corp (IGXT)

Intelgenx Technologies Corp (IGXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
CHANGES TO BOARD OF DIRECTORS OF GEEKCO

/CNW/ - Geekco Technologies Corporation (the "Corporation" or "Geekco") (TSXV: GKO) (OTCQB: GKOTF) is pleased to announce the appointments of André Godin and...

GKOTF : 0.0243 (-55.41%)
GKO.VN : 0.045 (-10.00%)
IGXT : 0.1670 (-3.75%)
IGX.TO : 0.2400 (+17.07%)
IntelGenx Announces Completion of Share Issuance in Payment of Principal and Interest on Debentures

SAINT LAURENT, Quebec, July 05, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) announces...

IGXT : 0.1670 (-3.75%)
IGX.TO : 0.2400 (+17.07%)
IntelGenx to Report First Quarter 2022 Financial Results on May 12, 2022 – Conference Call to Follow

SAINT LAURENT, Quebec, May 05, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical...

IGXT : 0.1670 (-3.75%)
IGX.TO : 0.2400 (+17.07%)
IntelGenx to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference

SAINT LAURENT, Quebec, April 26, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical...

IGXT : 0.1670 (-3.75%)
IGX.TO : 0.2400 (+17.07%)
IntelGenx Reports Fourth Quarter and Full-Year 2021 Financial Results

SAINT LAURENT, Quebec, March 24, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today...

IGXT : 0.1670 (-3.75%)
IGX.TO : 0.2400 (+17.07%)
IntelGenx to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022 – Conference Call to Follow

SAINT LAURENT, Quebec, March 17, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical...

IGXT : 0.1670 (-3.75%)
IGX.TO : 0.2400 (+17.07%)
First Patient Dosed in IntelGenx’s Resumed ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease

SAINT LAURENT, Quebec, Jan. 20, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Company”), a leader in...

IGXT : 0.1670 (-3.75%)
IGX.TO : 0.2400 (+17.07%)

Barchart Exclusives

JPMorgan Says This 1 Chip Stock Is a Strong Buy Now... And It’s Not What You Think It Is
J.P. Morgan upgraded Pepsi, citing expectations for improved performance. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar